MGEN - シグナル・ジェネティクス （Miragen Therapeutics Inc.）

Miragen Therapeutics Inc. shares closed this week 22.6% higher than it did at the end of last week. The stock is currently up 40.0% year-to-date, up 126.6% over the past 12 months, and up 136.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%. Trading Activity Shares traded as high as $25.67 and as low as $19.45 this week.Shares closed 2e+1% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 22.7% lower than the 10-day average and 44.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 0.6% higher than its 5-day moving average, 20.2% higher than its 20-day moving average, and 51.5% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 8.0% The company's stock price performance over the past 12 months beats the peer average by 8.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Miragen Therapeutics Inc. shares closed today 16.7% higher than it did at the end of yesterday. The stock is currently up 14.2% year-to-date, up 74.0% over the past 12 months, and up 78.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $23.90 and as low as $16.39 this week.Shares closed 3e+1% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 202.6% higher than the 10-day average and 332.3% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date lags the peer average by -49.7% The company's stock price performance over the past 12 months lags the peer average by -38.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Miragen Therapeutics Inc. shares closed the week 17.3% higher than it did at the end of last week. The stock is currently up 170.5% year-to-date, up 103.2% over the past 12 months, and up 68.6% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $19.95 and as low as $16.36 this week. Trading volume this week was 4.1% lower than the 10-day average and 45.1% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 12.6% higher than its 20-day moving average, and 36.5% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year beats its average peer by 7.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Miragen Therapeutics Inc. shares closed this week 22.6% higher than it did at the end of last week. The stock is currently up 40.0% year-to-date, up 126.6% over the past 12 months, and up 136.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%. Trading Activity Shares traded as high as $25.67 and as low as $19.45 this week.Shares closed 2e+1% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 22.7% lower than the 10-day average and 44.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 0.6% higher than its 5-day moving average, 20.2% higher than its 20-day moving average, and 51.5% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 8.0% The company's stock price performance over the past 12 months beats the peer average by 8.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Miragen Therapeutics Inc. shares closed today 16.7% higher than it did at the end of yesterday. The stock is currently up 14.2% year-to-date, up 74.0% over the past 12 months, and up 78.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $23.90 and as low as $16.39 this week.Shares closed 3e+1% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 202.6% higher than the 10-day average and 332.3% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date lags the peer average by -49.7% The company's stock price performance over the past 12 months lags the peer average by -38.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Miragen Therapeutics Inc. shares closed the week 17.3% higher than it did at the end of last week. The stock is currently up 170.5% year-to-date, up 103.2% over the past 12 months, and up 68.6% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $19.95 and as low as $16.36 this week. Trading volume this week was 4.1% lower than the 10-day average and 45.1% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 12.6% higher than its 20-day moving average, and 36.5% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year beats its average peer by 7.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Miragen Therapeutics Inc. shares closed this week 22.6% higher than it did at the end of last week. The stock is currently up 40.0% year-to-date, up 126.6% over the past 12 months, and up 136.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%. Trading Activity Shares traded as high as $25.67 and as low as $19.45 this week.Shares closed 2e+1% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 22.7% lower than the 10-day average and 44.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 0.6% higher than its 5-day moving average, 20.2% higher than its 20-day moving average, and 51.5% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 8.0% The company's stock price performance over the past 12 months beats the peer average by 8.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Miragen Therapeutics Inc. shares closed today 16.7% higher than it did at the end of yesterday. The stock is currently up 14.2% year-to-date, up 74.0% over the past 12 months, and up 78.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $23.90 and as low as $16.39 this week.Shares closed 3e+1% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 202.6% higher than the 10-day average and 332.3% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date lags the peer average by -49.7% The company's stock price performance over the past 12 months lags the peer average by -38.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Miragen Therapeutics Inc. shares closed the week 17.3% higher than it did at the end of last week. The stock is currently up 170.5% year-to-date, up 103.2% over the past 12 months, and up 68.6% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $19.95 and as low as $16.36 this week. Trading volume this week was 4.1% lower than the 10-day average and 45.1% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 12.6% higher than its 20-day moving average, and 36.5% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year beats its average peer by 7.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.